共 110 条
[1]
Montalescot G(2013)2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology Eur Heart J 34 2949-3003
[2]
Sechtem U(2015)Heart disease and stroke statistics—2015 update: a report from the American Heart Association Circulation 131 e29-322
[3]
Achenbach S(1997)Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators N Engl J Med 336 92-99
[4]
Mozaffarian D(2012)ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation 126 e3
[5]
Benjamin EJ(1994)Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration Lancet 344 563-570
[6]
Go AS(2005)Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis Circulation 111 2906-2912
[7]
Hlatky MA(2007)Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 1503-1516
[8]
Rogers WJ(2015)Effect of PCI on long-term survival in patients with stable ischemic heart disease N Engl J Med 373 1937-1946
[9]
Johnstone I(2009)A randomized trial of therapies for type 2 diabetes and coronary artery disease N Engl J Med 360 2503-2515
[10]
Fihn SD(2012)Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease N Engl J Med 367 991-1001